STUDY LAUNCH | The BIO-005: Malaria vaccine & Challenge Study is now open.
π Learn more about the study on the BIO-005 study page, linked here: www.ovg.ox.ac.uk/studies/bio005
@ovg.ox.ac.uk
The Oxford Vaccine Group is a research group at the University of Oxford. We conduct studies of new and improved vaccines for children and adults around the world. ovg.ox.ac.uk | ox.ac.uk
STUDY LAUNCH | The BIO-005: Malaria vaccine & Challenge Study is now open.
π Learn more about the study on the BIO-005 study page, linked here: www.ovg.ox.ac.uk/studies/bio005
NEWS | The United States sets out to pull mRNA vaccine funding through the cancellation of 22 mRNA vaccine projects, totalling $500m (Β£376m) in funding.
π Head directly to the Vaccine Knowledge website to learn more about mRNA vaccines, linked here: vaccineknowledge.ox.ac.uk/types-of-vac...
π§³ Whether you are headed to the Swiss alps or the sunny beaches of Spain this August, look no further for your next listen as Professor Sir Andrew Pollard has got you covered.
π Listen to The Oxford Colloquy on a range of platforms, linked here: www.ovg.ox.ac.uk/news/podcasts
STUDY ROUNDUP | With the month of July shortly coming to a close, there are a vast range of studies on-going at the Oxford Vaccine Group.
π Information about how to get involved with the studies can be found on the Oxford Vaccine Group's 'Find a Study' page, linked below:
NEWS | Recent research has shown age-related differences in the immune response to ChAdOx1 nCoV-19, the widely deployed vaccine during the height of the COVID-19 pandemic.
π Read the article in full on eBioMedicine, linked here: www.thelancet.com/journals/ebi...
NEWS | HRH The Duke of Gloucester Visits University of Oxfordβs Cutting-Edge Vaccine Facilities
His Royal Highness toured the OVG laboratories, met students and researchers, and learnt about current projects being undertaken across the group.
Link to find out more below
NEWS | A new publication in Springer Nature titled 'Safe Vaccine Administration' includes a chapter authored by Karen Ford and Rachel White, of the Oxford Vaccine Group.
π Head to Springer Nature to find the publication and the chapter in full, linked below
NEWS | An article recently published in The Lancet co-authored by Simon Drysdale, from the Oxford Vaccine Group, examines the vaccine effectiveness of an RSV vaccine.
π Find the full feature article on The Lancet, linked below
STUDY LAUNCH | A new study, LEGACY04, examining lymph nodes to assess immune responses in younger and older adults after immunisation with mRNA COVID-19 and seasonal influenza vaccine boosters has just opened.
π Learn more about the study on the OVG website, linked below
NEWS | Over the weekend, multiple news sources reported that Liverpool's Alder Hay Children's Hospital had confirmed the passing of a child after they had contracted measles.
π Head to the Vaccine Knowledge website to learn more about Measles and the MMR vaccine, linked below
NEWS | What can snot reveal about your health - A BBC Future article featuring Daniela Ferreira, Professor of Respiratory Infection and Vaccinology at the Oxford Vaccine Group.
π The full article can be found here on the BBC Future Health page: www.bbc.co.uk/future/artic...
NEWS | Children around the world face a death sentence because of anti-vaccine rhetoric.
A tragedy is unfolding in 2025 as a result of a sudden catastrophic reversal of life chances for the worldβs children.
@ajpollard1.bsky.social
observer.co.uk/news/opinion...
π’ The UK childhood immunisation schedule is changing from 1 July 2025.
π For full information on vaccines, the infectious diseases they protect against, and how vaccines work, visit vaccineknowledge.ox.ac.uk or speak to your GP.
EVENT | π Up next on the Oxford Vaccine Group events calendar: A one-day immunisation and influenza training course.
π Tuesday 15th of July or Wednesday 16th of July
π Interested in attending the training course? Find out more on the OVG events page, link below.
EVENT | With an exciting start to the IIC - The ESPID-Oxford Course we are close to rounding off day one! The excitement doesn't stop here though, we are ready for another jam packed day full of exciting talks about key areas of paediatric infection tomorrow!
#iic2025
STUDY UPDATE | π° There are numerous studies on-going at the Oxford Vaccine Group, so here is a round up of all the studies at OVG which are looking for participants to take part!
π More detail about the studies can be found on our website, linked below
NEWS | π MenB vaccine, developed by researchers at the University of Oxford, shows promising results in early-stage trial
π Read the article in full on the OVG website, link below
EVENT | There is now three days till the Infection and Immunity in Children ESPID-Oxford course is in full swing at the Mathematical Institute, University of Oxford.
Registration to the event has now closed but you can keep up to date with or learn more about #IIC2025 below
AWARDS & APPOINTMENTS | Join OVG in congratulating Elena Mitsi, Associate Professor of Infection & Mucosal Immunology, in her recognition by the BSI through her achievement of being awarded the 2025 British Society for Immunology Early Career Research Excellence Award.
19.06.2025 18:10 β π 1 π 0 π¬ 1 π 0EVENT RECAP | IMMPROVE at the Great Exhibition Road Festival, Imperial College London
If you would like to find out more about the work carried out by the IMMPROVE consortium you can find out more on their website, linked here: immprove.ac.uk
EVENT | Infection and Immunity in Children: The ESPID-Oxford Course
There is just under three weeks to go till the 22nd edition of the IIC: The ESPID-Oxford Course, find out more about the course in the link below.
NEWS | University of Oxfordβs Nipah vaccine granted support from the PRIME scheme by the EMA
π§ͺ The Oxford Vaccine Group is currently leading the NIV001 trial - phase 1 testing of the vaccine after promising earlier results.
π° The full article is linked below.